Scott, I., N. Oden, P. VanVeldhuisen, M. Ip, and B. Blodi. SCORE2 Report 17: Macular Thickness Fluctuations in Anti-VEGF-Treated Patients With Central or Hemiretinal Vein Occlusion. Graefe’s archive for clinical and experimental ophthalmology, 2021, p. Epub PubMed Text.
Abstract
Purpose: To evaluate macular thickness fluctuations and their association with visual acuity outcome in eyes with macular edema (ME) secondary to central (CRVO) or hemiretinal vein occlusion (HRVO) treated initially with intravitreal aflibercept or bevacizumab.
Keywords: Anti-VEGF treatment; Central retinal vein occlusion; Hemiretinal vein occlusion; Macular edema; Macular thickness fluctuation; Visual acuity.